In conclusion, this study has identified a single flavanol, (−)-epicatechin, to be effective at reducing Aβ production and pathology in wild-type neurons and in a transgenic model of AD and that this is most likely through modulation of BACE1 activity. The gene discussed is BACE1; the disease is Alzheimer disease.